Manchester-based Pimberly thinks that the time is ripe for expansion now that it has passed its $1 million annual recurring revenue (ARR) milestone earlier this year.
The outfit is am SaaS Product Information Management (PIM) and Digital Asset Management (DAM) platform provider and has annouced it is moving into scale mode, investing to accelerate growth and achieve an ARR target of $10 million.
Pimberly’s PIM platform acts as a central hub for all omnichannel product data, including descriptions, specifications, sizing, pricing, availability, imagery and videos for multiple brands, currencies and geographies. Its automation and intuitive “No-Code” UI streamline ERP/eComm workflows. This helps retailers, distributors and manufacturers to seamlessly expand into new marketplaces and territories, as well as rapidly increasing time to market and the agility of their products and services.
Pimberly’s rapid growth follows investment from NorthEdge Capital and the UK Government. This has enabled the company to double its headcount to 40 over the last 12 months. The team is now in the process of expanding its headquarters, taking two floors within St James’s Tower in central Manchester and investing in more staff for product development, go to market and customer success.
Martin Balaam, CEO of Pimberly, said: “As new Enterprise B2B SaaS companies will know, getting your first paying clients is a huge milestone, enabling you to focus on getting to the nirvana of the $1 million ARR target – I’m thrilled that businesses have so well received Pimberly. To surpass this target and focus on scaling to $10 million ARR so quickly is just awesome.
“It’s also a real indication that companies are increasingly focussing on their eComm/online strategies to fuel growth and can see the value that automated and effective product information management can have on their operational efficiency, their customer service and their bottom lines. This is a hugely exciting time for tech in the North West, and we’re delighted to be a part of its success.”